INDIGENOUS HEPATITIS A VACCINE
Bharat Bio's Rotavirus vaccine Rotavac may be unsafe for children: Study
A study found that Bharat Biotech's Rotavac vaccine used in the government's immunization program increases the risk of intussusception in infants, a condition where the intestine telescopes into itself, leading to potential serious consequences.
ICMR draws flak from experts over call for BHU study retraction
Universal Health Organisation (UHO) criticizes ICMR for questioning BHU researchers over Covaxin study, calling for academic freedom and data transparency. Study on Covaxin's side effects faces ICMR scrutiny, urging transparency and data access from ICMR. BHU study on Covid-19 vaccine side effects challenges academic censorship by ICMR. UHO condemns ICMR's censorship attempts on BHU's Covaxin study.
Covaxin demonstrated excellent safety record during studies: Bharat Biotech
Bharat Biotech asserted the safety of its Covid-19 vaccine, Covaxin, citing various studies published in peer-reviewed journals. This statement followed a report in The Economic Times regarding adverse events of special interest (AESI) reported by participants in an observational study on Covaxin. The company emphasized the need for comprehensive safety data in such studies, including comparisons with non-vaccinated subjects and those receiving other vaccines.
Good shot, bad shot: What you need to know about Covishield issue
Covishield Side Effects: Controversies surrounding vaccine side-effects persist despite Covid-19 waning. Covishield, developed by AstraZeneca and Oxford University, faces scrutiny in India following reports of rare side effects. Legal battles and demands for compensation have emerged as families of alleged victims seek justice. Experts stress the importance of understanding risks versus benefits in vaccine administration.
Polio vaccine shortage looms over India with Sanofi plants' shutdown
An impending crisis looms over India's supply of injectable poliomyelitis vaccine (IPV) as French drugmaker Sanofi has shut down its manufacturing plants in the country, halting production of its IPV brand ShanIPV in December 2023. Sanofi's closure has raised concerns about disruptions in India's polio eradication efforts, as it catered to over 80% of the country's IPV dose requirements.
Dr Reddy's to promote, distribute Sanofi vaccine brands in India
The announcement comes a day after Sanofi Healthcare India announced a separate partnership with Cipla to boost access to Sanofi's central nervous system medications across India.
- Go To Page 1
No impact on immune system of man who received over 200 COVID-19 vaccinations: Lancet study
Until now, it has been unclear what effects hypervaccination such as this would have on the immune system. Some scientists were of the opinion that immune cells would become less effective after becoming used to the antigens.
Russian President Vladimir Putin claims significant progress made towards Cancer vaccines
Russian President Vladimir Putin announced that Russian scientists are close to developing cancer vaccines, potentially revolutionizing cancer treatment globally. He shared this breakthrough at a Moscow forum on future technologies, expressing hope for their effective use in individual therapy. While Putin did not specify the targeted cancers or mechanisms, various countries and companies, including the UK and BioNTech, are actively working on similar treatments. This development comes amidst Russia's global distribution of the Sputnik V COVID-19 vaccine, with Putin highlighting vaccine safety and efficacy.
Budget 2024: Govt actively considering rolling out of HPV vaccine for cervical cancer, says FM
Budget 2024: During her Budget speech, Finance Minister Nirmala Sitharaman said that the government will encourage vaccination for girls in the age group of 9 to 14 years for providing prevention of cervical cancer. She added that the government is actively considering rolling out the HPV vaccine in the country’s immunisation programme.
IIL launches first indigenous Hepatitis A vaccine
Priced at ?2,150 per dose, it is a two-dose vaccine in which the first dose is administered at above 12 months of age and the second dose is given at least after 6 months of the first dose. The vaccine is also recommended for individuals who are at risk of exposure or travel to the regions with high hepatitis A prevalence. In addition to this people with occupational risk of infection and suffering from chronic liver diseases also need Hepatitis A vaccination.
Corbevax vaccine gets WHO Emergency Use Listing authorisation
The company supplied 100 million doses of Corbevax to the central government which were then utilized in pan-India immunization campaigns, mainly in children aged 12-14 years, the release said. Datla said that several companies which started vaccine development or manufacture during the COVID-19 pandemic exited later due to paucity of funds or lack of success.
Gaza faces 'perfect storm' of deadly diseases
The United Nations is tracking the incidence of 14 diseases with "epidemic potential" and is most concerned about soaring rates of dysentery, watery diarrhoea, and acute respiratory infections. Another expert warned that a diarrhoea outbreak "could happen as soon as tomorrow, unless many more aid trucks were let in and clean water was provided".
PM Modi praises 'The Vaccine War': Every Indian is feeling proud after watching film
Prime Minister Narendra Modi praised the film "The Vaccine War" for depicting the hard work of Indian scientists in fighting against COVID-19 and developing an affordable vaccine for India and the world. He also congratulated the makers for giving importance to the scientists and science of the country. The film, directed by Vivek Agnihotri, features Anupam Kher, Nana Patekar, Sapthami Gowda, and Pallavi Joshi, who also produced the film. Agnihotri expressed gratitude to PM Modi for acknowledging the contribution of Indian scientists.
SC dismisses plea against GlaxoSmithKline pharma for deficiency in service
A bench of Justices A S Bopanna and Prashant Kumar Mishra said the drug is made available in the market after certification and nothing has been placed on record to indicate that this is a drug which was available "of the shelf", without prescription.
Viral hepatitis could cause liver cancer: Here's what you need to know about prevention and treatment
In medical terms, hepatitis is explained as an inflammation of the liver, which is responsible for blood filtering, nutrient processing, and fighting infections. An inflamed liver can't perform its functions, leading to various health complications. One of the major causes of hepatitis is the hepatitis virus. There are other causes that could lead to hepatitis, including alcohol abuse and the use of certain drugs.
World Hepatitis Day: Know about causes, symptoms and risk factors
July 28 is reserved to promote awareness of this insidious and deadly virus.
Health experts bat for adult vaccination programmes in India
Doctors and health experts have stressed that people, especially those above 50 years, must receive the recommended vaccines, shining light on the ignorance or scant knowledge regarding adult vaccination in India. Vaccines have a significant impact on overall health, they said, expressing concern regarding the poor status of adult vaccination in India. Vaccination can prevent over 95 per cent of deaths caused by vaccine-preventable diseases in the country.
The next big advance in cancer treatment could be a vaccine
Researchers predict that the next big advance in cancer treatment will be the development of vaccines to shrink tumors and stop cancer from coming back. Unlike traditional vaccines that prevent disease, these vaccines boost the immune system to find and kill cancer cells.
mRNA booster vaccine Gemcovac-OM for Omicron launched at Rs 2,292/dose. Who can take and precautions
Gemcovac-OM, the booster vaccine for Omicron from Emcure's subsidiary Gennova, had recently received the nod from the office of the Drug Control General of India (DCGI) for Emergency Use Authorization (EUA). Individuals above 18 years and who have received either Covaxin or Covishield as primary vaccination can take it as a booster for active immunization for the prevention of COVID-19.
Sops on cards to make Vaccine Vial Monitors
The Niti Aayog is spearheading the initiative and is holding discussions with multiple stakeholders to understand the potential and challenges that the country faces in the manufacturing of VVMs.
Is Hepatitis A dangerous? Here is everything you need to know about Hepatitis A
India has a high number of chronic Hepatitis B and C cases, while Hepatitis A can lead to acute liver failure, it is usually a short-term illness as compared to other strains. The virus is highly contagious and is often transmitted through contaminated food and water. Symptoms can include yellowing skin and eyes, fatigue, fever, loss of appetite, and light-colored stools.
View: India's Covid-19 vaccines delivery a triple-A rated story
In financial markets, triple-A-rated bonds are considered the highest form of creditworthy instruments, as they carry a very low risk of default and the rating shows that the issuer is able to meet its financial commitment. Transposed to the economics of vaccines, the triple-A rating would be underpinned by the Availability, Access and Affordability of vaccines.
World Hepatitis Day: Experiencing fatigue, joint pain & itching? Time to get vaccinated
Hepatitis A and E, an infection of the liver, can last for four-five weeks.
Population-based screening for hepatitis in West Bengal, announces Mamata Banerjee
"Vaccine of Hepatitis B is provided to all newborns to give lifelong immunity. We shall be taking treatment services to sub district level and population based screening. Let's all take up the challenge on this day to eliminate Hepatitis in West Bengal," she added.
World Hepatitis Day 2022: All you need to know about this viral disease
Hepatitis virus has five commonly known strains: Type A, B, C, D. All of them affect the liver but there are some key differences in origin, transmission and severity of the disease. Hepatitis can be preventable with immunization and manageable, but there is no cure at present.
Drug regulator approves country's first indigenously developed HPV by Serum Institute
"For the first time there will be an Indian HPV vaccine to treat cervical cancer in women that is both affordable and accessible," Adar Poonawalla, CEO, SII tweeted. He said that the company will launch it later this year.
33 countries report 650 cases of mysterious hepatitis in kids: WHO
Out of the 650 probable cases, at least 38 (6 per cent) children have required transplants, and nine (1 per cent) deaths have been reported to WHO. About one-third of the cases, 222, are in the UK, and another 216 have been reported in the US.
Children in US in danger of Pediatric Hepatitis, doctors warned
Adenovirus can cause serious illnesses in people with a weak immune system. People with cardiac problems or respiratory diseases could also land up with severe infections as a result.
Load More
